Figure 4. SUMF1 overexpression is significantly correlated with poor DSS in subgroups of with glioma. (A) IDH mutant patients; (B) Patients with the non-codel in 1p/19q codeletion; (C) Female; (D) Male; (E) Age ≤60; (F) Age >60; (G) Astrocytoma; (H) Oligodendroglioma.